Genmab Takes Full Control of Acasunlimab Development Program
5/8 11:50
Company Announcement Genmab to assume sole responsibility for the continued development and potential commercialization of acasunlimab BioNTech has opted not to participate in the further development of the acasunlimab program under the parties’ existing collaboration agreement The overall...